Characteristics of rheumatoid arthritis with immunodeficiency-associated lymphoproliferative disorders to regress spontaneously by the withdrawal of methotrexate and their clinical course: A retrospective, multicenter, case-control study

被引:23
作者
Kuramoto, Nobuo [1 ]
Saito, Shuntaro [2 ]
Fujii, Takao [1 ,3 ]
Kaneko, Yuko [2 ,3 ]
Saito, Rintaro [4 ]
Tanaka, Masao [3 ,5 ]
Takada, Hideto [6 ]
Nakano, Kazuhisa [3 ,7 ]
Saito, Kazuyoshi [3 ,8 ]
Sugimoto, Naoki [6 ]
Sasaki, Sho [9 ]
Harigai, Masayoshi [3 ,6 ]
Suzuki, Yasuo [3 ,9 ]
机构
[1] Wakayama Med Univ, Dept Rheumatol & Clin Immunol, 811-1 Kimiidera, Wakayama 6418509, Japan
[2] Keio Univ, Sch Med, Dept Internal Med, Dept Rheumatol, Tokyo, Japan
[3] Kyoto Univ, Japan Coll Rheumatol, Working Grp Rheumatoid Arthrit Associated Lymphop, Kyoto, Japan
[4] Kyoto Univ, Dept Rheumatol & Clin Immunol, Kyoto, Japan
[5] Kyoto Univ, Grad Sch Med, Dept Adv Med Rheumat Dis, Kyoto, Japan
[6] Tokyo Womens Med Univ, Sch Med, Dept Rheumatol, Tokyo, Japan
[7] Univ Occupat & Environm Hlth, Sch Med, Dept Internal Med 1, Fukuoka, Japan
[8] Tobata Gen Hosp, Fukuoka, Japan
[9] Tokai Univ, Hachioji Hosp, Div Rheumatol, Tokyo, Japan
关键词
Rheumatoid arthritis; lymphoproliferative disorder; methotrexate; spontaneous regression; prognostic factors;
D O I
10.1080/14397595.2021.1879362
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To investigate clinical characteristics and time course of lymphoproliferative disorders (LPDs) in rheumatoid arthritis (RA) patients after methotrexate (MTX) discontinuation, in those who achieved spontaneous regression (SR). Methods We retrospectively reviewed clinical data from RA patients with LPDs obtained from eight institutions between 2000 and 2017 and compared clinical and pathological findings between SR and non-SR groups. Results Among 232 RA patients with LPDs, 216 were treated with MTX at the onset of LPD and 144 (66.7%) achieved SR after MTX discontinuation. Higher MTX doses, high titers of anti-CCP antibodies (>13.5 U/mL), and lower LDH and soluble IL-2 receptor levels were associated with SR. Lymphocyte count was decreased at LPD onset and increased at 2 weeks after MTX discontinuation in the SR group. Epstein-Barr virus-positive mucocutaneous ulcer, reactive lymphoid hyperplasia and unclassifiable B-cell lymphoma, were more frequent in the SR than in the non-SR group. In multivariable analysis, diffuse large B-cell lymphomas was an independent predictive factor for non-SR. In the patients with SR, 73.9% achieved partial or complete regression as early as 2 weeks after MTX discontinuation. Conclusion SR and non-SR in RA patients with LPDs after MTX discontinuation were associated with certain clinical characteristics.
引用
收藏
页码:24 / 31
页数:8
相关论文
共 18 条
[1]   Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis [J].
Baecklund, E ;
Iliadou, A ;
Askling, J ;
Ekborn, A ;
Backlin, C ;
Granath, F ;
Catrina, AT ;
Rosenquist, R ;
Feltelius, N ;
Sundström, C ;
Klareskog, L .
ARTHRITIS AND RHEUMATISM, 2006, 54 (03) :692-701
[2]   Revised response criteria for malignant lymphoma [J].
Cheson, Bruce D. ;
Pfistner, Beate ;
Juweid, Malik E. ;
Gascoyne, Randy D. ;
Specht, Lena ;
Horning, Sandra J. ;
Coiffier, Bertrand ;
Fisher, Richard I. ;
Hagenbeek, Anton ;
Zucca, Emanuele ;
Rosen, Steven T. ;
Stroobants, Sigrid ;
Lister, T. Andrew ;
Hoppe, Richard T. ;
Dreyling, Martin ;
Tobinai, Kensei ;
Vose, Julie M. ;
Connors, Joseph M. ;
Federico, Massimo ;
Diehl, Volker .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (05) :579-586
[3]   Incidence of Malignancy and the Risk of Lymphoma in Japanese Patients with Rheumatoid Arthritis Compared to the General Population [J].
Hashimoto, Atsushi ;
Chiba, Noriyuki ;
Tsuno, Hirotaka ;
Komiya, Akiko ;
Furukawa, Hiroshi ;
Matsui, Toshihiro ;
Nishino, Jinju ;
Tohma, Shigeto .
JOURNAL OF RHEUMATOLOGY, 2015, 42 (04) :564-571
[4]  
Hoshida Y, 2007, J RHEUMATOL, V34, P322
[5]   Methotrexate/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression [J].
Ichikawa, Ayako ;
Arakawa, Fumiko ;
Kiyasu, Junichi ;
Sato, Kensaku ;
Miyoshi, Hiroaki ;
Niino, Daisuke ;
Kimura, Yoshizo ;
Takeuchi, Masanori ;
Yoshida, Maki ;
Ishibashi, Yukinao ;
Nakashima, Shinji ;
Sugita, Yasuo ;
Miura, Osamu ;
Ohshima, Koichi .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2013, 91 (01) :20-28
[6]   Methotrexate-associated lymphoproliferative disorders: management by watchful waiting and observation of early lymphocyte recovery after methotrexate withdrawal [J].
Inui, Yumiko ;
Matsuoka, Hiroshi ;
Yakushijin, Kimikazu ;
Okamura, Atsuo ;
Shimada, Takaki ;
Yano, Shingo ;
Takeuchi, Mai ;
Ito, Mitsuhiro ;
Murayama, Tohru ;
Yamamoto, Katsuya ;
Itoh, Tomoo ;
Aiba, Keisuke ;
Minami, Hironobu .
LEUKEMIA & LYMPHOMA, 2015, 56 (11) :3045-3051
[7]   Japan College of Rheumatology guideline for the use of methotrexate in patients with rheumatoid arthritis [J].
Kameda, Hideto ;
Fujii, Takao ;
Nakajima, Ayako ;
Koike, Ryuji ;
Sagawa, Akira ;
Kanbe, Katsuaki ;
Tomita, Tetsuya ;
Harigai, Masayoshi ;
Suzuki, Yasuo .
MODERN RHEUMATOLOGY, 2019, 29 (01) :31-40
[8]   Association of Higher Methotrexate Dose With Lymphoproliferative Disease Onset in Rheumatoid Arthritis Patients [J].
Kameda, Tomohiro ;
Dobashi, Hiroaki ;
Miyatake, Nobuyuki ;
Inoo, Masayuki ;
Onishi, Ikuko ;
Kurata, Noriyuki ;
Mitsunaka, Hiroki ;
Kawakami, Kimihiro ;
Fukumoto, Tetsuya ;
Susaki, Kentaro ;
Izumikawa, Miharu ;
Nakashima, Shusaku ;
Shimada, Hiromi ;
Takeuchi, Yohei ;
Haba, Reiji ;
Mano, Shohei ;
Onishi, Hiroaki ;
Imataki, Osamu ;
Matsunaga, Takuya .
ARTHRITIS CARE & RESEARCH, 2014, 66 (09) :1302-1309
[9]   Prognostic factors of methotrexate-associated lymphoproliferative disorders associated with rheumatoid arthritis and plausible application of biological agents [J].
Katsuyama, Takayuki ;
Sada, Ken-Ei ;
Yan, Minglu ;
Zeggar, Sonia ;
Hiramatsu, Sumie ;
Miyawaki, Yoshia ;
Ohashi, Keiji ;
Morishita, Michiko ;
Watanabe, Haruki ;
Katsuyama, Eri ;
Takano-Narazaki, Mariko ;
Toyota-Tatebe, Noriko ;
Sunahori-Watanabe, Katsue ;
Kawabata, Tomoko ;
Miyake, Kohei ;
Kiguchi, Toru ;
Wada, Jun .
MODERN RHEUMATOLOGY, 2017, 27 (05) :773-777
[10]   Methotrexate-associated Lymphoproliferative Disorders in Patients With Rheumatoid Arthritis Clinicopathologic Features and Prognostic Factors [J].
Kurita, Daisuke ;
Miyoshi, Hiroaki ;
Ichikawa, Ayako ;
Kato, Koji ;
Imaizumi, Yoshitaka ;
Seki, Ritsuko ;
Sato, Kensaku ;
Sasaki, Yuya ;
Kawamoto, Keisuke ;
Shimono, Joji ;
Yamada, Kyohei ;
Muto, Reiji ;
Kizaki, Masahiro ;
Nagafuji, Koji ;
Tamaru, Jun-ichi ;
Tokuhira, Michihide ;
Ohshima, Koichi .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2019, 43 (07) :869-884